nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0981	0.17	CbGbCtD
Rivastigmine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0981	0.17	CbGbCtD
Rivastigmine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0875	0.152	CbGbCtD
Rivastigmine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0823	0.143	CbGbCtD
Rivastigmine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0556	0.0966	CbGbCtD
Rivastigmine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0531	0.0921	CbGbCtD
Rivastigmine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0473	0.0821	CbGbCtD
Rivastigmine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0277	0.0482	CbGbCtD
Rivastigmine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0262	0.0455	CbGbCtD
Rivastigmine—Tapentadol—SLC6A4—chronic obstructive pulmonary disease	0.00223	1	CrCbGaD
Rivastigmine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00216	0.0634	CbGpPWpGaD
Rivastigmine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00191	0.056	CbGpPWpGaD
Rivastigmine—BCHE—diaphragm—chronic obstructive pulmonary disease	0.00164	0.692	CbGeAlD
Rivastigmine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00156	0.0458	CbGpPWpGaD
Rivastigmine—ACHE—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.00097	0.0284	CbGpPWpGaD
Rivastigmine—ACHE—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000949	0.0278	CbGpPWpGaD
Rivastigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	0.000917	0.0269	CbGpPWpGaD
Rivastigmine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	0.000818	0.024	CbGpPWpGaD
Rivastigmine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000793	0.0233	CbGpPWpGaD
Rivastigmine—ACHE—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000736	0.0216	CbGpPWpGaD
Rivastigmine—ACHE—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000689	0.0202	CbGpPWpGaD
Rivastigmine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000626	0.0184	CbGpPWpGaD
Rivastigmine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000608	0.0178	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.000606	0.0178	CbGpPWpGaD
Rivastigmine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000524	0.0154	CbGpPWpGaD
Rivastigmine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000504	0.0148	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000475	0.014	CbGpPWpGaD
Rivastigmine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000471	0.0138	CbGpPWpGaD
Rivastigmine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000455	0.0134	CbGpPWpGaD
Rivastigmine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000409	0.012	CbGpPWpGaD
Rivastigmine—ACHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.000407	0.012	CbGpPWpGaD
Rivastigmine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000389	0.0114	CbGpPWpGaD
Rivastigmine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000381	0.0112	CbGpPWpGaD
Rivastigmine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000373	0.0109	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000369	0.0108	CbGpPWpGaD
Rivastigmine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000366	0.0107	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.000363	0.0107	CbGpPWpGaD
Rivastigmine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000357	0.0105	CbGpPWpGaD
Rivastigmine—ACHE—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.000352	0.0103	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000344	0.0101	CbGpPWpGaD
Rivastigmine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000342	0.01	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00033	0.00967	CbGpPWpGaD
Rivastigmine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000329	0.00966	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000316	0.00927	CbGpPWpGaD
Rivastigmine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000302	0.00885	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000301	0.00884	CbGpPWpGaD
Rivastigmine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00873	CbGpPWpGaD
Rivastigmine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000286	0.00838	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000283	0.0083	CbGpPWpGaD
Rivastigmine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.0083	CbGpPWpGaD
Rivastigmine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000271	0.00794	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000269	0.00788	CbGpPWpGaD
Rivastigmine—ACHE—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000256	0.0075	CbGpPWpGaD
Rivastigmine—ACHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000253	0.00743	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000253	0.00741	CbGpPWpGaD
Rivastigmine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000249	0.0073	CbGpPWpGaD
Rivastigmine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000239	0.00702	CbGpPWpGaD
Rivastigmine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000238	0.000617	CcSEcCtD
Rivastigmine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000238	0.000616	CcSEcCtD
Rivastigmine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000615	CcSEcCtD
Rivastigmine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000236	0.000612	CcSEcCtD
Rivastigmine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.000607	CcSEcCtD
Rivastigmine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.000603	CcSEcCtD
Rivastigmine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.000601	CcSEcCtD
Rivastigmine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000231	0.000601	CcSEcCtD
Rivastigmine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.0006	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000231	0.00677	CbGpPWpGaD
Rivastigmine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00023	0.000598	CcSEcCtD
Rivastigmine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.000597	CcSEcCtD
Rivastigmine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.000596	CcSEcCtD
Rivastigmine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.000595	CcSEcCtD
Rivastigmine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000595	CcSEcCtD
Rivastigmine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.000592	CcSEcCtD
Rivastigmine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000592	CcSEcCtD
Rivastigmine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00059	CcSEcCtD
Rivastigmine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.000587	CcSEcCtD
Rivastigmine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.000587	CcSEcCtD
Rivastigmine—BCHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000226	0.00662	CbGpPWpGaD
Rivastigmine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.000586	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000226	0.000586	CcSEcCtD
Rivastigmine—ACHE—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000225	0.00661	CbGpPWpGaD
Rivastigmine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000224	0.000581	CcSEcCtD
Rivastigmine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.000581	CcSEcCtD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000224	0.00657	CbGpPWpGaD
Rivastigmine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000579	CcSEcCtD
Rivastigmine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000223	0.000578	CcSEcCtD
Rivastigmine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000222	0.00653	CbGpPWpGaD
Rivastigmine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000575	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000221	0.000574	CcSEcCtD
Rivastigmine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000221	0.000573	CcSEcCtD
Rivastigmine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.000573	CcSEcCtD
Rivastigmine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00022	0.000571	CcSEcCtD
Rivastigmine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.000571	CcSEcCtD
Rivastigmine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000219	0.000569	CcSEcCtD
Rivastigmine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.000567	CcSEcCtD
Rivastigmine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000218	0.000566	CcSEcCtD
Rivastigmine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.000566	CcSEcCtD
Rivastigmine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000565	CcSEcCtD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000218	0.00638	CbGpPWpGaD
Rivastigmine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000217	0.000563	CcSEcCtD
Rivastigmine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00056	CcSEcCtD
Rivastigmine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00056	CcSEcCtD
Rivastigmine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000215	0.000558	CcSEcCtD
Rivastigmine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.000557	CcSEcCtD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.0063	CbGpPWpGaD
Rivastigmine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.000555	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000214	0.000555	CcSEcCtD
Rivastigmine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000214	0.000554	CcSEcCtD
Rivastigmine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.000554	CcSEcCtD
Rivastigmine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000214	0.000554	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.000553	CcSEcCtD
Rivastigmine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00055	CcSEcCtD
Rivastigmine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00055	CcSEcCtD
Rivastigmine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00055	CcSEcCtD
Rivastigmine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00055	CcSEcCtD
Rivastigmine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.000549	CcSEcCtD
Rivastigmine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000548	CcSEcCtD
Rivastigmine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000548	CcSEcCtD
Rivastigmine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000545	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000209	0.000544	CcSEcCtD
Rivastigmine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000209	0.000543	CcSEcCtD
Rivastigmine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.000541	CcSEcCtD
Rivastigmine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00054	CcSEcCtD
Rivastigmine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000207	0.000538	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000538	CcSEcCtD
Rivastigmine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.000537	CcSEcCtD
Rivastigmine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000535	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000535	CcSEcCtD
Rivastigmine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.000534	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000206	0.00604	CbGpPWpGaD
Rivastigmine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000534	CcSEcCtD
Rivastigmine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.000533	CcSEcCtD
Rivastigmine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.000532	CcSEcCtD
Rivastigmine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000531	CcSEcCtD
Rivastigmine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00053	CcSEcCtD
Rivastigmine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00053	CcSEcCtD
Rivastigmine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.000529	CcSEcCtD
Rivastigmine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.000528	CcSEcCtD
Rivastigmine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000527	CcSEcCtD
Rivastigmine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000203	0.000527	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.000526	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000203	0.000526	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.000524	CcSEcCtD
Rivastigmine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.000523	CcSEcCtD
Rivastigmine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.000519	CcSEcCtD
Rivastigmine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.000519	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000198	0.000515	CcSEcCtD
Rivastigmine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000515	CcSEcCtD
Rivastigmine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000515	CcSEcCtD
Rivastigmine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.000511	CcSEcCtD
Rivastigmine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000197	0.000511	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000196	0.00576	CbGpPWpGaD
Rivastigmine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000196	0.000508	CcSEcCtD
Rivastigmine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000196	0.000508	CcSEcCtD
Rivastigmine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.000508	CcSEcCtD
Rivastigmine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.000508	CcSEcCtD
Rivastigmine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000507	CcSEcCtD
Rivastigmine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.000506	CcSEcCtD
Rivastigmine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000503	CcSEcCtD
Rivastigmine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.000502	CcSEcCtD
Rivastigmine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000193	0.000502	CcSEcCtD
Rivastigmine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000193	0.000502	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000193	0.00567	CbGpPWpGaD
Rivastigmine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000193	0.0005	CcSEcCtD
Rivastigmine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.0005	CcSEcCtD
Rivastigmine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000192	0.000499	CcSEcCtD
Rivastigmine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000499	CcSEcCtD
Rivastigmine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000192	0.000498	CcSEcCtD
Rivastigmine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000192	0.000498	CcSEcCtD
Rivastigmine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000497	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.000496	CcSEcCtD
Rivastigmine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.000492	CcSEcCtD
Rivastigmine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.00049	CcSEcCtD
Rivastigmine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000489	CcSEcCtD
Rivastigmine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000488	CcSEcCtD
Rivastigmine—BCHE—respiratory system—chronic obstructive pulmonary disease	0.000188	0.079	CbGeAlD
Rivastigmine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.000482	CcSEcCtD
Rivastigmine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00048	CcSEcCtD
Rivastigmine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00048	CcSEcCtD
Rivastigmine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.000474	CcSEcCtD
Rivastigmine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000182	0.000474	CcSEcCtD
Rivastigmine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000182	0.000473	CcSEcCtD
Rivastigmine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000472	CcSEcCtD
Rivastigmine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000472	CcSEcCtD
Rivastigmine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000468	CcSEcCtD
Rivastigmine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000179	0.000464	CcSEcCtD
Rivastigmine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000178	0.000461	CcSEcCtD
Rivastigmine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.000461	CcSEcCtD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00517	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00516	CbGpPWpGaD
Rivastigmine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.000455	CcSEcCtD
Rivastigmine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000175	0.000455	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000175	0.00514	CbGpPWpGaD
Rivastigmine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000454	CcSEcCtD
Rivastigmine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000174	0.000452	CcSEcCtD
Rivastigmine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000447	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000172	0.00506	CbGpPWpGaD
Rivastigmine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000172	0.000445	CcSEcCtD
Rivastigmine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00044	CcSEcCtD
Rivastigmine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00044	CcSEcCtD
Rivastigmine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000438	CcSEcCtD
Rivastigmine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000436	CcSEcCtD
Rivastigmine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000435	CcSEcCtD
Rivastigmine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000433	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000167	0.0049	CbGpPWpGaD
Rivastigmine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000166	0.000431	CcSEcCtD
Rivastigmine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.000429	CcSEcCtD
Rivastigmine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.000427	CcSEcCtD
Rivastigmine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.000425	CcSEcCtD
Rivastigmine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000164	0.000425	CcSEcCtD
Rivastigmine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00016	0.000416	CcSEcCtD
Rivastigmine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000415	CcSEcCtD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00464	CbGpPWpGaD
Rivastigmine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00041	CcSEcCtD
Rivastigmine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.000409	CcSEcCtD
Rivastigmine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000157	0.000409	CcSEcCtD
Rivastigmine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000405	CcSEcCtD
Rivastigmine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000405	CcSEcCtD
Rivastigmine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000405	CcSEcCtD
Rivastigmine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000405	CcSEcCtD
Rivastigmine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000405	CcSEcCtD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00458	CbGpPWpGaD
Rivastigmine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000155	0.000403	CcSEcCtD
Rivastigmine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.000403	CcSEcCtD
Rivastigmine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000402	CcSEcCtD
Rivastigmine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000402	CcSEcCtD
Rivastigmine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000401	CcSEcCtD
Rivastigmine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000401	CcSEcCtD
Rivastigmine—BCHE—bronchus—chronic obstructive pulmonary disease	0.000154	0.065	CbGeAlD
Rivastigmine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000154	0.0004	CcSEcCtD
Rivastigmine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000153	0.000397	CcSEcCtD
Rivastigmine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000153	0.000397	CcSEcCtD
Rivastigmine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000396	CcSEcCtD
Rivastigmine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000395	CcSEcCtD
Rivastigmine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000152	0.000394	CcSEcCtD
Rivastigmine—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.000151	0.0636	CbGeAlD
Rivastigmine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000391	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000389	CcSEcCtD
Rivastigmine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000389	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000149	0.00437	CbGpPWpGaD
Rivastigmine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000386	CcSEcCtD
Rivastigmine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000385	CcSEcCtD
Rivastigmine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000383	CcSEcCtD
Rivastigmine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000383	CcSEcCtD
Rivastigmine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000382	CcSEcCtD
Rivastigmine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000382	CcSEcCtD
Rivastigmine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000382	CcSEcCtD
Rivastigmine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000382	CcSEcCtD
Rivastigmine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00038	CcSEcCtD
Rivastigmine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000145	0.00427	CbGpPWpGaD
Rivastigmine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000375	CcSEcCtD
Rivastigmine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000374	CcSEcCtD
Rivastigmine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.00037	CcSEcCtD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00417	CbGpPWpGaD
Rivastigmine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000368	CcSEcCtD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00412	CbGpPWpGaD
Rivastigmine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000362	CcSEcCtD
Rivastigmine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000361	CcSEcCtD
Rivastigmine—BCHE—trachea—chronic obstructive pulmonary disease	0.000139	0.0584	CbGeAlD
Rivastigmine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000359	CcSEcCtD
Rivastigmine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000358	CcSEcCtD
Rivastigmine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000356	CcSEcCtD
Rivastigmine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000354	CcSEcCtD
Rivastigmine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00035	CcSEcCtD
Rivastigmine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000348	CcSEcCtD
Rivastigmine—ACHE—Metabolism—APIP—chronic obstructive pulmonary disease	0.000133	0.00392	CbGpPWpGaD
Rivastigmine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000342	CcSEcCtD
Rivastigmine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00034	CcSEcCtD
Rivastigmine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000337	CcSEcCtD
Rivastigmine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000333	CcSEcCtD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00376	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00375	CbGpPWpGaD
Rivastigmine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00033	CcSEcCtD
Rivastigmine—ACHE—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000127	0.00371	CbGpPWpGaD
Rivastigmine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000323	CcSEcCtD
Rivastigmine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000318	CcSEcCtD
Rivastigmine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000315	CcSEcCtD
Rivastigmine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000315	CcSEcCtD
Rivastigmine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000313	CcSEcCtD
Rivastigmine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000312	CcSEcCtD
Rivastigmine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00031	CcSEcCtD
Rivastigmine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00031	CcSEcCtD
Rivastigmine—BCHE—Metabolism—APIP—chronic obstructive pulmonary disease	0.000119	0.00349	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00338	CbGpPWpGaD
Rivastigmine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000298	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000113	0.00331	CbGpPWpGaD
Rivastigmine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000292	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000111	0.00327	CbGpPWpGaD
Rivastigmine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000288	CcSEcCtD
Rivastigmine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000287	CcSEcCtD
Rivastigmine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000286	CcSEcCtD
Rivastigmine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000285	CcSEcCtD
Rivastigmine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00028	CcSEcCtD
Rivastigmine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000278	CcSEcCtD
Rivastigmine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000278	CcSEcCtD
Rivastigmine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000277	CcSEcCtD
Rivastigmine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000272	CcSEcCtD
Rivastigmine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000269	CcSEcCtD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00303	CbGpPWpGaD
Rivastigmine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000268	CcSEcCtD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00299	CbGpPWpGaD
Rivastigmine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000264	CcSEcCtD
Rivastigmine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000264	CcSEcCtD
Rivastigmine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000263	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000262	CcSEcCtD
Rivastigmine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000261	CcSEcCtD
Rivastigmine—BCHE—lung—chronic obstructive pulmonary disease	9.97e-05	0.042	CbGeAlD
Rivastigmine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	9.88e-05	0.000256	CcSEcCtD
Rivastigmine—Oedema—Prednisone—chronic obstructive pulmonary disease	9.75e-05	0.000253	CcSEcCtD
Rivastigmine—Infection—Prednisone—chronic obstructive pulmonary disease	9.68e-05	0.000251	CcSEcCtD
Rivastigmine—Shock—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.000249	CcSEcCtD
Rivastigmine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.000248	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.52e-05	0.00279	CbGpPWpGaD
Rivastigmine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.51e-05	0.000247	CcSEcCtD
Rivastigmine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.000246	CcSEcCtD
Rivastigmine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.42e-05	0.000245	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.37e-05	0.00275	CbGpPWpGaD
Rivastigmine—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.000241	CcSEcCtD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.24e-05	0.00271	CbGpPWpGaD
Rivastigmine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.88e-05	0.00023	CcSEcCtD
Rivastigmine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.87e-05	0.00023	CcSEcCtD
Rivastigmine—ACHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.84e-05	0.00259	CbGpPWpGaD
Rivastigmine—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.82e-05	0.000229	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.77e-05	0.00257	CbGpPWpGaD
Rivastigmine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000227	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GC—chronic obstructive pulmonary disease	8.6e-05	0.00252	CbGpPWpGaD
Rivastigmine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.58e-05	0.000223	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.49e-05	0.00249	CbGpPWpGaD
Rivastigmine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.47e-05	0.00022	CcSEcCtD
Rivastigmine—Rash—Prednisolone—chronic obstructive pulmonary disease	8.46e-05	0.000219	CcSEcCtD
Rivastigmine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.45e-05	0.000219	CcSEcCtD
Rivastigmine—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.000218	CcSEcCtD
Rivastigmine—Headache—Prednisolone—chronic obstructive pulmonary disease	8.4e-05	0.000218	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.38e-05	0.00246	CbGpPWpGaD
Rivastigmine—Constipation—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.000216	CcSEcCtD
Rivastigmine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000208	CcSEcCtD
Rivastigmine—ACHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8e-05	0.00235	CbGpPWpGaD
Rivastigmine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	7.97e-05	0.000207	CcSEcCtD
Rivastigmine—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.97e-05	0.000207	CcSEcCtD
Rivastigmine—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.89e-05	0.00231	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.82e-05	0.0023	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.81e-05	0.00229	CbGpPWpGaD
Rivastigmine—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.000201	CcSEcCtD
Rivastigmine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.0002	CcSEcCtD
Rivastigmine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.0002	CcSEcCtD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.71e-05	0.00226	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	7.69e-05	0.00226	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	7.67e-05	0.00225	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.37e-05	0.00216	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.28e-05	0.00214	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000186	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.18e-05	0.00211	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.15e-05	0.0021	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.13e-05	0.00209	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.08e-05	0.00208	CbGpPWpGaD
Rivastigmine—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.99e-05	0.000181	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	6.91e-05	0.00203	CbGpPWpGaD
Rivastigmine—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.9e-05	0.000179	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	6.86e-05	0.00201	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.81e-05	0.002	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.71e-05	0.00197	CbGpPWpGaD
Rivastigmine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.000173	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	6.56e-05	0.00192	CbGpPWpGaD
Rivastigmine—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000167	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.43e-05	0.00189	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.37e-05	0.00187	CbGpPWpGaD
Rivastigmine—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000161	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	6.16e-05	0.00181	CbGpPWpGaD
Rivastigmine—Rash—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.000159	CcSEcCtD
Rivastigmine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000159	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	6.13e-05	0.0018	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.12e-05	0.0018	CbGpPWpGaD
Rivastigmine—Headache—Prednisone—chronic obstructive pulmonary disease	6.11e-05	0.000158	CcSEcCtD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.04e-05	0.00177	CbGpPWpGaD
Rivastigmine—Nausea—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.00015	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.68e-05	0.00167	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.48e-05	0.00161	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.4e-05	0.00158	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.11e-05	0.0015	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.04e-05	0.00148	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	4.94e-05	0.00145	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	4.78e-05	0.0014	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.7e-05	0.00138	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.69e-05	0.00138	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GCLC—chronic obstructive pulmonary disease	4.64e-05	0.00136	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.63e-05	0.00136	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.45e-05	0.00131	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	4.41e-05	0.00129	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.39e-05	0.00129	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.33e-05	0.00127	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	4.26e-05	0.00125	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CTGF—chronic obstructive pulmonary disease	4.24e-05	0.00124	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.19e-05	0.00123	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	4.14e-05	0.00122	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.91e-05	0.00115	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.86e-05	0.00113	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	3.78e-05	0.00111	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.63e-05	0.00106	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.58e-05	0.00105	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.53e-05	0.00104	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.48e-05	0.00102	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.28e-05	0.000962	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.26e-05	0.000956	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.21e-05	0.000943	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	3.18e-05	0.000932	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.99e-05	0.000878	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.91e-05	0.000853	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.87e-05	0.000841	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.84e-05	0.000833	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.83e-05	0.000831	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.67e-05	0.000783	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.53e-05	0.000743	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.37e-05	0.000696	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.31e-05	0.000677	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.14e-05	0.000629	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALB—chronic obstructive pulmonary disease	1.93e-05	0.000566	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.93e-05	0.000566	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.91e-05	0.000559	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.000541	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.74e-05	0.00051	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	1.72e-05	0.000505	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	1.65e-05	0.000483	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.6e-05	0.00047	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.34e-05	0.000392	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.32e-05	0.000387	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.26e-05	0.00037	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.25e-05	0.000365	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.23e-05	0.00036	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000342	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.14e-05	0.000334	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.05e-05	0.000307	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.73e-06	0.000256	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.61e-06	0.000253	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.03e-06	0.000236	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	7.91e-06	0.000232	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.61e-06	0.000223	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.57e-06	0.000222	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.17e-06	0.000152	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.95e-06	0.000145	CbGpPWpGaD
